NCT03900260 is a NA clinical trial of Softec HP1 Intraocular Lens in Aphakia, sponsored by Lenstec Incorporated.

Who is sponsoring NCT03900260?

NCT03900260 is sponsored by Lenstec Incorporated.

What drugs are being tested in NCT03900260?

Interventions in NCT03900260: Softec HP1 Intraocular Lens.

Is NCT03900260 still recruiting?

NCT03900260 is currently completed. Last updated 15 February 2024.

Last reviewed 2024-02-15 · How we verify

NCT03900260

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Evaluation of the Lenstec Softec HP1 Intraocular Lens

Completed NA Last updated 15 February 2024

What this trial tests

NA trial testing Softec HP1 Intraocular Lens in Aphakia in 87 participants. Completed in 22 July 2021.

Timeline

25 April 2019

Primary endpoint
22 July 2021

22 July 2021

Quick facts

Lead sponsor	Lenstec Incorporated
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	87
Start date	25 April 2019
Primary completion	22 July 2021
Estimated completion	22 July 2021
Sites	3 locations across United Kingdom

Drugs / interventions tested

Softec HP1 Intraocular Lens

Conditions studied

Aphakia — all drugs for Aphakia →

Sponsor

Lenstec Incorporated

Who can join

21 and older, any sex, with Aphakia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is designed as a post market evaluation of the Softec HP1 IOL for continuance of the CE certificate. The primary effectiveness endpoint is to evaluate the safety and performance levels produced by this IOL in patients requiring standard cataract surgery. There will be no change from standard procedure, other than 1 extra post op evaluation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Aphakia

Currently open trials in the same condition.

NCT06258707 — Bicentric Clinical Investigation to Assess Safety and Performance of LuxBoost IOL · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03900260 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Lenstec Incorporated
Last refreshed: 15 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03900260.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing